Bruker Corporation's stock surged 10.50% in pre-market trading on Wednesday, following the release of its first-quarter 2026 financial results that exceeded analyst expectations.

The scientific instruments maker reported adjusted earnings per share of $0.31 for Q1 2026, beating the IBES estimate of $0.23. Revenue for the quarter reached $823.4 million, also surpassing the consensus estimate of $796.4 million. The company reaffirmed its full-year outlook, projecting revenue between $3.57 billion and $3.60 billion and adjusted EPS in the range of $2.10 to $2.15, both aligning with market expectations.

Despite noting continued weakness in U.S. academic demand and headwinds from tariffs and currency impacts, the company highlighted solid academic orders outside the U.S. and strong AI-driven demand in semiconductor metrology and laboratory software as positive drivers. The better-than-expected quarterly performance and maintained guidance have fueled investor optimism, leading to the significant pre-market gain.